Case Study: Vertebrobasilar insufficiency imitating cerebrovasculitis in a patient with systemic lupus erythematosus
DOI: 10.54647/pm31135 70 Downloads 5655 Views
Author(s)
Abstract
We report a 45-year-old patient who was treated at the Rheumatology Clinic
Keywords
Vertebrobasilar insufficiency, cerebrovasculitis
Cite this paper
Mariela Geneva-Popova, Stanislava Popova,
Case Study: Vertebrobasilar insufficiency imitating cerebrovasculitis in a patient with systemic lupus erythematosus
, SCIREA Journal of Medicine.
Volume 5, Issue 5, October 2021 | PP. 52-61.
10.54647/pm31135
References
[ 1 ] | Mills J., “Systemic lupus erythematosus”, N Engl J Med. 1994 Jun 30;330(26):1871-9. |
[ 2 ] | Sanna G., M. Bertolaccini, M. Cuadrado et al., “Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies”, J Rheumatol. May 2003;30(5):985-92. |
[ 3 ] | Azarpazhooh M., N. Mokhber, E. Orouji et al., “Microembolic signals in patients with systemic lupus erythematosus”, Can J Neurol Sci. May 2010;37(3):371-5. |
[ 4 ] | Ellis S., A. Verity, “Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955—1977”, Semin Arthritis Rheum., Feb 1979;8(3):212-21. |
[ 5 ] | AlSaleh J., V. Jassim, M. ElSayed, et al., “Clinical and immunological manifestations in 151 SLE patients living in Dubai”, Lupus, 2008;17(1):62-6. |
[ 6 ] | Zanardi V., L. Magna, L. Costallat, “Cerebral atrophy related to corticotherapy in systemic lupus erythematosus (SLE)”, Clin Rheumatol., 2001;20(4):245-50. |
[ 7 ] | Castellino G., M. Padovan, A. Bortoluzzi et al., “Single photon emission computed tomography and magnetic resonance imaging evaluation in SLE patients with and without neuropsychiatric involvement”, Rheumatology (Oxford). Mar 2008;47(3): 319-23. |
[ 8 ] | Wang H., G. Yunjie, M. Yanhong et al., “”Performance of the 2019 EULAR/ACR systemic lupus erythematosus classification criteria in a cohort of patients with biopsy-confirmed lupus nephritis”, Lupus Science & Medicine 2021;8: e000458. |
[ 9 ] | Lisnevskaia L., G. Murphy, D. Isenberg, Systemic lupus erythematosus”, Lancet 2014; 384:1878–88. |
[ 10 ] | Aringer M., K. Costenbader, D. Daikh et al., “European League against Rheumatism/American College of rheumatology classification criteria for systemic lupus erythematosus”, Ann Rheum Dis 2019;78:1151–9. |
[ 11 ] | Aringer M., K. Costenbader, D. Daikh, et al., “European League against Rheumatism/American College of rheumatology classification criteria for systemic lupus erythematosus”, Arthritis Rheumatol 2019;71:1400–12. |
[ 12 ] | Suda M., M. Kishimoto, S. Ohde et al., “Validation of the 2019 ACR/ EULAR classification criteria of systemic lupus erythematosus in 100 Japanese patients: a real-world setting analysis”, Clin Rheumatol 2020;39:1823–7. |
[ 13 ] | Dörner T., R. Furie, “Novel paradigms in systemic lupus erythematosus”, Lancet 2019; 393:2344–58. |
[ 14 ] | Bendorius M., Po. Chrystelle, S.Muller and H. Jeltsch-David, “From Systemic Inflammation to Neuroinflammation: The Case of Neurolupus”, Int. J. Mol. Sci. 2018, 19(11), 3588. |
[ 15 ] | Cohen D., E. Rijnink, R. Nabuurs et al., “Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement”, Rheumatology (Oxford). 2017 Jan;56 (1):77-86. |
[ 16 ] | Mackay M., C. Tang A. Vo, “Advanced neuroimaging in neuropsychiatric systemic lupus erythematosus”, Curr Opin Neurol. 2020 Jun;33(3):353-361. |
[ 17 ] | Appenzeller S., T. Lilian, L. Costallat, F. Cendes, “Neurolupus”, Arch Neurol. 2006 Mar; 63 (3):458-60. |
[ 18 ] | Chang-Youh Tsai, Ko-Jen Li, Song-Chou Hsieh et al., “What's wrong with neutrophils in lupus?”, Clin Exp Rheumatol, Jul-Aug 2019;37(4):684-693. |
[ 19 ] | Wieliczko M., J. Matuszkiewicz-Rowińska, “Systemic lupus erythematosus - news 2017”, Wiad Lek. 2017; 70(6 pt 2):1201-1204. |
[ 20 ] | Oku K., T. Atsumi, “Systemic lupus erythematosus: nothing stale her infinite variety”, Mod Rheumatol., 2018 Sep;28(5):758-765. |
[ 21 ] | Pathak S.,C. Mohan, “Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models”, Arthritis Res Ther. 2011;13(5):241. |
[ 22 ] | Scolding N., F. Joseph, “The neuropathology and pathogenesis of systemic lupus erythematosus”, Neuropathol Appl Neurobiol. 2002 Jun; 28(3):173-89. |
[ 23 ] | Julkunen H., “Systemic lupus erythematosus”, Duodecim. 2012;128(1):51-61. |